Bortezomib in patients with relapsed or refractory mantle cell lymphoma (MCL): Preliminary results of the PINNACLE study-Reference-Cited by-同舟云学术

Bortezomib in patients with relapsed or refractory mantle cell lymphoma (MCL): Preliminary results of the PINNACLE study

Published:2005-06 Issue:16_suppl Volume:23 Page:6563-6563
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Goy A.¹,Bernstein S.¹,Kahl B.¹,Epner E.¹,Leonard J. P.¹,Stadtmauer E.¹,Morgan D.¹,Belt R.¹,Baidas S.¹,Fisher R. I.¹

Affiliation:

1. MD Anderson Cancer Ctr, Houston, TX; Univ of Rochester, Rochester, NY; Univ Hosp - Madison, Madison, WI; Oregon Health Sciences Univ, Portland, OR; New York Weill-Cornell Medcl Ctr, New York, NY; Univ of Pennsylvania Cancer Ctr, Philadelphia, PA; Vanderbilt Univ, Nashville, TN; Kansas City Cancer Ctr, Kansas City, MO; Georgetown Univ Medcl Ctr, Washington, DC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.6563

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab;Biology of Blood and Marrow Transplantation;2017-11

2. Expanding Therapeutic Options in Mantle Cell Lymphoma;Clinical Lymphoma and Myeloma;2007-08

3. New Directions in the Treatment of Mantle Cell Lymphoma: An Overview;Clinical Lymphoma and Myeloma;2006-10

4. Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?;British Journal of Haematology;2006-08

5. Treatment of mantle cell lymphoma: Current approach and future directions;Critical Reviews in Oncology/Hematology;2006-06